Patient Case #2: Third-Line Options for HER2+ mBC With Lung Disease
November 30, 2021

In another patient case, panelists break down third-line therapy options for someone with HER2+ metastatic breast cancer and lung disease.

Presentation: Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current State
November 30, 2021

Drs. Gupta and Brown review a recently published paper by Grivas et al. (2019) on the use of checkpoint inhibitors for maintenance therapy to prolong the benefits of frontline therapy while minimizing toxicity in solid tumors.

Patient Case #1: Second-Line Therapy for HER2+ mBC
November 30, 2021

Moving to optimal treatment approaches in second-line therapy, experts close out a patient case of HER2+ metastatic breast cancer.

Tamoxifen Plus Extended Letrozole Treatment Yields Improvement in Disease-Free Survival for Postmenopausal HR+ Breast Cancer
November 30, 2021

Patients who were given extended 5-year treatment with letrozole plus 2 to 3 years of tamoxifen experienced an improvement in disease-free survival compared with 2 to 3 years of treatment with letrozole.

Imaging Drug Pafolacianine Approved by FDA for Detection of Ovarian Cancer During Surgery
November 29, 2021

Imaging drug imaging drug pafolacianine was approved by the FDA to detect ovarian cancer lesions in patients during surgery.

Radiotherapy Is the Favored Treatment for Localized Prostate Cancer Among Those Living Remotely
November 29, 2021

Men with localized prostate cancer were most likely to select treatment with radiotherapy over surgery and its associated adverse effects.

Reduction in Cancer Screenings During COVID-19 May Lead to More Late-Stage Disease, Poorer Outcomes
November 29, 2021

Late-stage cancer and poor outcomes for patients may occur as a result of low screening numbers during the COVID-19 pandemic.

Community-Based Physical Activity Programs Help to Improve in HRQOL in Underserved Breast Cancer Survivors
November 29, 2021

Breast cancer survivors who are minorities or medically underserved appear to experience a benefit in health-related quality of life after taking part in a community-based physical activity program.

2021 Pipeline Updates: Upcoming Innovations in Non–Small Cell Lung Cancer
November 29, 2021

As the year 2021 comes to a close, CancerNetwork® reviews ongoing clinical research and upcoming innovations in the non–small cell lung cancer space.

Don Dizon, MD, on Improving Treatment Strategies for Transgender Patients With Cancer
November 28, 2021

Don Dizon, MD, FACP, FASCO, discusses the need to improve treatment strategies for transgender patients with cancer.